Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy.
暂无分享,去创建一个
D. Bostwick | E. Bergstralh | H. Zincke | D G Bostwick | E J Bergstralh | M L Blute | H Zincke | S E Lerner | J T Eickholt | S. Lerner | M. Blute | J. T. Eickholt
[1] T. Therneau,et al. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. , 1989, Mayo Clinic proceedings.
[2] O. Culp. Radical Perineal Prostatectomy: Its Past, Present and Possible Future , 1967 .
[3] M. Frydenberg,et al. Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. , 1993, Urology.
[4] W. Catalona,et al. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. , 1994, The Journal of urology.
[5] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[6] Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. , 1988 .
[7] J. McNeal. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. , 1992, Human pathology.
[8] T. Stamey,et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.
[9] T. Therneau,et al. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. , 1989, The Journal of urology.
[10] P. Walsh,et al. Cancer control following anatomical radical prostatectomy: an interim report. , 1991, The Journal of urology.
[11] M. Blute,et al. Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome. , 1991, The Journal of urology.
[12] D. Cox. Regression Models and Life-Tables , 1972 .
[13] T. Stamey,et al. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate , 1990, Cancer.
[14] Montie Je. 1992 staging system for prostate cancer , 1993 .
[15] J. Oesterling,et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.
[16] D. Gleason,et al. Histologic Grading and Staging of Prostatic Carcinoma , 1981 .
[17] M. Kattan,et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. , 1995, The Journal of urology.
[18] H. Zincke,et al. Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation) , 1991, The Journal of urology.
[19] J. Eggleston,et al. Radical prostatectomy in the management of carcinoma of the prostate: probable causes of some therapeutic failures. , 1972, The Journal of urology.
[20] R. Vessella,et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. , 1989, The Journal of urology.
[21] D. Bostwick,et al. Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. , 1994, The Journal of urology.
[22] G. Gray,et al. The palpable nodule of prostatic cancer. Results 15 years after radical excision. , 1968, JAMA.
[23] T. Fleming,et al. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma confined to the prostate. , 1984, The Journal of urology.
[24] J. Oesterling,et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. , 1990, The Journal of urology.
[25] Galina Pizov,et al. Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.
[26] D. Hoak,et al. Prostate cancer: correlation of digital rectal examination, transrectal ultrasound and prostate specific antigen levels with tumor volumes in radical prostatectomy specimens. , 1990, The Journal of urology.
[27] Myron Tanncnbaum,et al. Urologic pathology: The prostate , 1977 .
[28] W. Catalona,et al. Clinical use of prostate specific antigen in patients with prostate cancer. , 1989, The Journal of urology.
[29] A. Partin,et al. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease. , 1995, The Journal of urology.
[30] A W Partin,et al. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. , 1993, The Journal of urology.
[31] H. Zincke. Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome. , 1989, Urology.